04:18 PM EST, 03/05/2024 (MT Newswires) -- Cedric Francois, Director, Chief Executive Officer, on March 01, 2024, sold 250,000 shares in Apellis Pharmaceuticals ( APLS ) for $16,028,706. Following the Form 4 filing with the SEC, Francois has control over a total of 2,035,230 shares of the company, with 313,662 shares held directly and 1,721,568 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760224008505/xslF345X03/form4.xml